$ACTC Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Ocata Therapeutics, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of all insider trading transactions in Ocata Therapeutics, Inc.. Get notifications about new insider transactions in Ocata Therapeutics, Inc. for free.

Page:   < prev 1 2 3 4 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Nov 18 2013ACTCOcata Therapeutics ...Heffernan Michael ThomasDirectorOption ExerciseA0.06125,0007,500125,000
Nov 18 2013ACTCOcata Therapeutics ...Heffernan Michael ThomasDirectorOption ExerciseA0.06125,0007,500125,000
Nov 12 2013ACTCOcata Therapeutics ...Lanza RobertChief Scientific Of ...Option ExerciseA0.061,285,71479,7141,285,714
Nov 12 2013ACTCOcata Therapeutics ...Lanza RobertChief Scientific Of ...GrantA0.001,285,714023,943,82225.2 M to 23.9 M (-5.10 %)
Oct 02 2013ACTCOcata Therapeutics ...SHAPIRO ALAN CDirectorGrantA0.00555,177018,833,54218.3 M to 18.8 M (+3.04 %)
Oct 02 2013ACTCOcata Therapeutics ...PERRY GREGORY DDirectorGrantA0.00125,00001,016,667891.7 K to 1 M (+14.02 %)
Oct 02 2013ACTCOcata Therapeutics ...LOSHITZER ZOHARDirectorGrantA0.00125,00001,058,333933.3 K to 1.1 M (+13.39 %)
Oct 02 2013ACTCOcata Therapeutics ...LANGER ROBERTDirectorGrantA0.00125,00004,100,0004 M to 4.1 M (+3.14 %)
Oct 02 2013ACTCOcata Therapeutics ...Heffernan Michael ThomasDirectorGrantA0.00125,0000850,000725 K to 850 K (+17.24 %)
Jul 01 2013ACTCOcata Therapeutics ...SHAPIRO ALAN CDirectorGrantA0.00543,831015,594,16715.1 M to 15.6 M (+3.61 %)
Jul 01 2013ACTCOcata Therapeutics ...PERRY GREGORY DDirectorGrantA0.00125,0000891,667766.7 K to 891.7 K (+16.30 %)
Jul 01 2013ACTCOcata Therapeutics ...Myles Edward HCFO and EVP of Corp ...Option ExerciseA0.0814,000,0001,089,20014,000,000
Jul 01 2013ACTCOcata Therapeutics ...LOSHITZER ZOHARDirectorGrantA0.00125,0000933,333808.3 K to 933.3 K (+15.46 %)
Jul 01 2013ACTCOcata Therapeutics ...LANGER ROBERTDirectorGrantA0.00125,00003,975,0003.9 M to 4 M (+3.25 %)
Jul 01 2013ACTCOcata Therapeutics ...Heffernan Michael ThomasDirectorGrantA0.00125,0000725,000600 K to 725 K (+20.83 %)
Apr 15 2013ACTCOcata Therapeutics ...Rabin Gary HCEO & CFOSellS0.081,000,00079,2006,000,0017 M to 6 M (-14.29 %)
Apr 15 2013ACTCOcata Therapeutics ...Rabin Gary HCEO & CFOSellS0.07650,00045,5657,000,0017.7 M to 7 M (-8.50 %)
Apr 15 2013ACTCOcata Therapeutics ...Rabin Gary HCEO & CFOSellS0.07350,00025,0257,650,0018 M to 7.7 M (-4.37 %)
Apr 15 2013ACTCOcata Therapeutics ...Rabin Gary HCEO & CFOSellS0.08391,44432,0988,000,0018.4 M to 8 M (-4.66 %)
Apr 15 2013ACTCOcata Therapeutics ...Rabin Gary HCEO & CFOSellS0.08608,55650,0238,391,4459 M to 8.4 M (-6.76 %)
Apr 15 2013ACTCOcata Therapeutics ...Rabin Gary HCEO & CFOSellS0.081,000,00078,4009,000,00110 M to 9 M (-10.00 %)
Apr 15 2013ACTCOcata Therapeutics ...Rabin Gary HCEO & CFOSellS0.07350,00025,37510,000,00110.4 M to 10 M (-3.38 %)
Apr 15 2013ACTCOcata Therapeutics ...Rabin Gary HCEO & CFOSellS0.0824,5001,96010,350,00110.4 M to 10.4 M (-0.24 %)
Apr 15 2013ACTCOcata Therapeutics ...Rabin Gary HCEO & CFOSellS0.0880,0006,44010,374,50110.5 M to 10.4 M (-0.77 %)
Apr 15 2013ACTCOcata Therapeutics ...Rabin Gary HCEO & CFOSellS0.0895,4717,66610,454,50110.5 M to 10.5 M (-0.90 %)
Apr 15 2013ACTCOcata Therapeutics ...Rabin Gary HCEO & CFOSellS0.07388,09026,58410,549,97210.9 M to 10.5 M (-3.55 %)
Apr 15 2013ACTCOcata Therapeutics ...Rabin Gary HCEO & CFOSellS0.07290,00020,79310,938,06211.2 M to 10.9 M (-2.58 %)
Apr 15 2013ACTCOcata Therapeutics ...Rabin Gary HCEO & CFOSellS0.08122,0009,82111,228,06211.4 M to 11.2 M (-1.07 %)
Apr 15 2013ACTCOcata Therapeutics ...Rabin Gary HCEO & CFOSellS0.08199,91016,65311,350,06211.5 M to 11.4 M (-1.73 %)
Apr 15 2013ACTCOcata Therapeutics ...Rabin Gary HCEO & CFOSellS0.18625,000109,50011,549,97212.2 M to 11.5 M (-5.13 %)
Apr 15 2013ACTCOcata Therapeutics ...Rabin Gary HCEO & CFOSellS0.14720,920104,38912,174,97212.9 M to 12.2 M (-5.59 %)
Apr 15 2013ACTCOcata Therapeutics ...Rabin Gary HCEO & CFOSellS0.14787,429111,65712,895,89213.7 M to 12.9 M (-5.75 %)
Apr 15 2013ACTCOcata Therapeutics ...Rabin Gary HCEO & CFOSellS0.15491,65071,38813,683,32114.2 M to 13.7 M (-3.47 %)
Apr 15 2013ACTCOcata Therapeutics ...Rabin Gary HCEO & CFOSellS0.17539,98791,69014,174,97114.7 M to 14.2 M (-3.67 %)
Apr 15 2013ACTCOcata Therapeutics ...Rabin Gary HCEO & CFOSellS0.16707,913115,95614,714,95815.4 M to 14.7 M (-4.59 %)
Apr 15 2013ACTCOcata Therapeutics ...Rabin Gary HCEO & CFOSellS0.16135,10021,94015,422,87115.6 M to 15.4 M (-0.87 %)
Apr 15 2013ACTCOcata Therapeutics ...Rabin Gary HCEO & CFOSellS0.17667,000110,32215,557,97116.2 M to 15.6 M (-4.11 %)
Apr 15 2013ACTCOcata Therapeutics ...Rabin Gary HCEO & CFOSellS0.19266,89851,93816,224,97116.5 M to 16.2 M (-1.62 %)
Apr 15 2013ACTCOcata Therapeutics ...Rabin Gary HCEO & CFOSellS0.18733,102130,12616,491,86917.2 M to 16.5 M (-4.26 %)
Apr 15 2013ACTCOcata Therapeutics ...Rabin Gary HCEO & CFOSellS0.17390,99368,07217,224,97117.6 M to 17.2 M (-2.22 %)
Apr 15 2013ACTCOcata Therapeutics ...Rabin Gary HCEO & CFOSellS0.19250,00047,22517,615,96417.9 M to 17.6 M (-1.40 %)
Apr 15 2013ACTCOcata Therapeutics ...Rabin Gary HCEO & CFOSellS0.19250,00048,70017,865,96418.1 M to 17.9 M (-1.38 %)
Apr 01 2013ACTCOcata Therapeutics ...SHAPIRO ALAN CDirectorGrantA0.00525,534015,050,33614.5 M to 15.1 M (+3.62 %)
Apr 01 2013ACTCOcata Therapeutics ...PERRY GREGORY DDirectorGrantA0.00125,0000766,667641.7 K to 766.7 K (+19.48 %)
Apr 01 2013ACTCOcata Therapeutics ...LOSHITZER ZOHARDirectorGrantA0.00125,0000808,333683.3 K to 808.3 K (+18.29 %)
Apr 01 2013ACTCOcata Therapeutics ...LANGER ROBERTDirectorGrantA0.00125,00003,850,0003.7 M to 3.9 M (+3.36 %)
Apr 01 2013ACTCOcata Therapeutics ...Heffernan Michael ThomasDirectorGrantA0.00125,0000600,000475 K to 600 K (+26.32 %)
Feb 26 2013ACTCOcata Therapeutics ...Heffernan Michael ThomasDirectorOption ExerciseA0.06500,00028,950500,000
Feb 26 2013ACTCOcata Therapeutics ...LANGER ROBERTDirectorOption ExerciseA0.06500,00028,950500,000
Feb 26 2013ACTCOcata Therapeutics ...PERRY GREGORY DDirectorOption ExerciseA0.06500,00028,950500,000
Feb 26 2013ACTCOcata Therapeutics ...LOSHITZER ZOHARDirectorOption ExerciseA0.06500,00028,950500,000
Feb 26 2013ACTCOcata Therapeutics ...SHAPIRO ALAN CDirectorOption ExerciseA0.06500,00028,950500,000
Jan 04 2013ACTCOcata Therapeutics ...SHAPIRO ALAN CDirectorGrantA0.00580,348014,524,80213.9 M to 14.5 M (+4.16 %)
Jan 04 2013ACTCOcata Therapeutics ...PERRY GREGORY DDirectorGrantA0.00125,0000641,667516.7 K to 641.7 K (+24.19 %)
Jan 04 2013ACTCOcata Therapeutics ...LOSHITZER ZOHARDirectorGrantA0.00125,0000683,333558.3 K to 683.3 K (+22.39 %)
Jan 04 2013ACTCOcata Therapeutics ...LANGER ROBERTDirectorGrantA0.00125,00003,725,0003.6 M to 3.7 M (+3.47 %)
Jan 04 2013ACTCOcata Therapeutics ...Heffernan Michael ThomasDirectorGrantA0.00125,0000475,000350 K to 475 K (+35.71 %)
Dec 18 2012ACTCOcata Therapeutics ...Lanza RobertChief Scientific Of ...SellS0.0643,0002,58026,476,22726.5 M to 26.5 M (-0.16 %)
Dec 18 2012ACTCOcata Therapeutics ...Lanza RobertChief Scientific Of ...SellS0.06100,0005,94026,519,22726.6 M to 26.5 M (-0.38 %)
Dec 18 2012ACTCOcata Therapeutics ...Lanza RobertChief Scientific Of ...SellS0.06150,0008,89526,619,22726.8 M to 26.6 M (-0.56 %)
Dec 18 2012ACTCOcata Therapeutics ...Lanza RobertChief Scientific Of ...SellS0.06545,49032,18426,769,22727.3 M to 26.8 M (-2.00 %)
Dec 18 2012ACTCOcata Therapeutics ...Lanza RobertChief Scientific Of ...SellS0.0640,0002,34027,314,71727.4 M to 27.3 M (-0.15 %)
Dec 18 2012ACTCOcata Therapeutics ...Lanza RobertChief Scientific Of ...SellS0.06440,00025,52027,354,71727.8 M to 27.4 M (-1.58 %)
Dec 18 2012ACTCOcata Therapeutics ...Lanza RobertChief Scientific Of ...SellS0.0620,0001,15827,794,71727.8 M to 27.8 M (-0.07 %)
Dec 18 2012ACTCOcata Therapeutics ...Lanza RobertChief Scientific Of ...GrantA0.001,285,714027,814,71726.5 M to 27.8 M (+4.85 %)
Oct 24 2012ACTCOcata Therapeutics ...SHAPIRO ALAN CDirectorGrantA0.00452,117013,944,45413.5 M to 13.9 M (+3.35 %)
Oct 03 2012ACTCOcata Therapeutics ...LANGER ROBERTDirectorGrantA0.00125,00003,600,0003.5 M to 3.6 M (+3.60 %)
Oct 03 2012ACTCOcata Therapeutics ...PERRY GREGORY DDirectorGrantA0.00125,0000516,667391.7 K to 516.7 K (+31.91 %)
Oct 03 2012ACTCOcata Therapeutics ...LOSHITZER ZOHARDirectorGrantA0.00125,0000558,333433.3 K to 558.3 K (+28.85 %)
Oct 03 2012ACTCOcata Therapeutics ...Heffernan Michael ThomasDirectorGrantA0.00125,0000350,000225 K to 350 K (+55.56 %)
Aug 09 2012ACTCOcata Therapeutics ...PERRY GREGORY DDirectorOption ExerciseA0.09500,00042,500500,000
Aug 09 2012ACTCOcata Therapeutics ...LOSHITZER ZOHARDirectorOption ExerciseA0.09500,00042,500500,000
Aug 09 2012ACTCOcata Therapeutics ...LANGER ROBERTDirectorOption ExerciseA0.09500,00042,500500,000
Aug 02 2012ACTCOcata Therapeutics ...SHAPIRO ALAN CDirectorOption ExerciseA0.09500,00042,500500,000
Aug 02 2012ACTCOcata Therapeutics ...Heffernan Michael ThomasDirectorOption ExerciseA0.08362,02230,410362,022
Aug 01 2012ACTCOcata Therapeutics ...Lanza RobertChief Scientific Of ...SellS0.08500,00040,00026,529,00327 M to 26.5 M (-1.85 %)
Aug 01 2012ACTCOcata Therapeutics ...Lanza RobertChief Scientific Of ...SellS0.08190,00015,58027,029,00327.2 M to 27 M (-0.70 %)
Aug 01 2012ACTCOcata Therapeutics ...Lanza RobertChief Scientific Of ...SellS0.08546,79344,29027,219,00327.8 M to 27.2 M (-1.97 %)
Aug 01 2012ACTCOcata Therapeutics ...Lanza RobertChief Scientific Of ...SellS0.08151,50012,13527,765,79627.9 M to 27.8 M (-0.54 %)
Aug 01 2012ACTCOcata Therapeutics ...Lanza RobertChief Scientific Of ...SellS0.08611,70748,93727,917,29628.5 M to 27.9 M (-2.14 %)
Jul 26 2012ACTCOcata Therapeutics ...Lanza RobertChief Scientific Of ...GrantA0.001,285,714028,529,00327.2 M to 28.5 M (+4.72 %)
Jul 26 2012ACTCOcata Therapeutics ...Lanza RobertChief Scientific Of ...GrantA0.001,285,714027,243,28926 M to 27.2 M (+4.95 %)
Jul 16 2012ACTCOcata Therapeutics ...LOSHITZER ZOHARDirectorGrantA0.00125,0000433,333308.3 K to 433.3 K (+40.54 %)
Jul 10 2012ACTCOcata Therapeutics ...LANGER ROBERTDirectorGrantA0.00125,00003,475,0003.4 M to 3.5 M (+3.73 %)
Jul 10 2012ACTCOcata Therapeutics ...Heffernan Michael ThomasDirectorGrantA0.00125,0000225,000100 K to 225 K (+125.00 %)
Jul 09 2012ACTCOcata Therapeutics ...SHAPIRO ALAN CDirectorOption ExerciseA0.19500,00095,000500,000
Jul 09 2012ACTCOcata Therapeutics ...SHAPIRO ALAN CDirectorOption ExerciseA1.3550,00067,50050,000
Jul 09 2012ACTCOcata Therapeutics ...SHAPIRO ALAN CDirectorOption ExerciseA2.4850,000124,00050,000
Jul 09 2012ACTCOcata Therapeutics ...SHAPIRO ALAN CDirectorGrantA0.00509,720023,488,06123 M to 23.5 M (+2.22 %)
Jul 09 2012ACTCOcata Therapeutics ...SHAPIRO ALAN CDirectorGrantA0.00292,832022,978,34122.7 M to 23 M (+1.29 %)
Jul 09 2012ACTCOcata Therapeutics ...SHAPIRO ALAN CDirectorGrantA0.00125,000022,685,52922.6 M to 22.7 M (+0.55 %)
Jul 09 2012ACTCOcata Therapeutics ...SHAPIRO ALAN CDirectorGrantA0.005,532,198022,560,50917 M to 22.6 M (+32.49 %)
Jul 09 2012ACTCOcata Therapeutics ...SHAPIRO ALAN CDirectorGrantA0.0013,846017,028,31117 M to 17 M (+0.08 %)
Jul 09 2012ACTCOcata Therapeutics ...SHAPIRO ALAN CDirectorGrantA0.00500,000017,014,46516.5 M to 17 M (+3.03 %)
Jul 09 2012ACTCOcata Therapeutics ...SHAPIRO ALAN CDirectorGrantA0.00100,982016,514,46516.4 M to 16.5 M (+0.62 %)
Jul 09 2012ACTCOcata Therapeutics ...SHAPIRO ALAN CDirectorGrantA0.00406,324016,413,48316 M to 16.4 M (+2.54 %)
Jul 09 2012ACTCOcata Therapeutics ...SHAPIRO ALAN CDirectorGrantA0.00554,845016,007,15915.5 M to 16 M (+3.59 %)
Jul 09 2012ACTCOcata Therapeutics ...SHAPIRO ALAN CDirectorGrantA0.00798,184015,452,31414.7 M to 15.5 M (+5.45 %)
Jul 09 2012ACTCOcata Therapeutics ...SHAPIRO ALAN CDirectorGrantA0.00683,273014,654,13014 M to 14.7 M (+4.89 %)
Jul 09 2012ACTCOcata Therapeutics ...SHAPIRO ALAN CDirectorGrantA0.00559,979013,970,85713.4 M to 14 M (+4.18 %)
Jul 09 2012ACTCOcata Therapeutics ...SHAPIRO ALAN CDirectorGrantA0.00593,662013,410,87812.8 M to 13.4 M (+4.63 %)
Jul 09 2012ACTCOcata Therapeutics ...SHAPIRO ALAN CDirectorGrantA0.00473,649012,817,21612.3 M to 12.8 M (+3.84 %)
Jul 09 2012ACTCOcata Therapeutics ...SHAPIRO ALAN CDirectorGrantA0.00584,310012,343,56711.8 M to 12.3 M (+4.97 %)
Jul 09 2012ACTCOcata Therapeutics ...SHAPIRO ALAN CDirectorGrantA0.00447,376011,759,25711.3 M to 11.8 M (+3.95 %)
Jul 09 2012ACTCOcata Therapeutics ...SHAPIRO ALAN CDirectorGrantA0.00416,229011,311,88110.9 M to 11.3 M (+3.82 %)
Jul 09 2012ACTCOcata Therapeutics ...SHAPIRO ALAN CDirectorGrantA0.00882,604010,895,65210 M to 10.9 M (+8.81 %)
Jul 09 2012ACTCOcata Therapeutics ...SHAPIRO ALAN CDirectorGrantA0.005,000,000010,013,0485 M to 10 M (+99.74 %)
Jul 09 2012ACTCOcata Therapeutics ...SHAPIRO ALAN CDirectorGrantA0.00424,73605,013,0484.6 M to 5 M (+9.26 %)
Jul 09 2012ACTCOcata Therapeutics ...SHAPIRO ALAN CDirectorGrantA0.00437,49404,588,3124.2 M to 4.6 M (+10.54 %)
Jul 09 2012ACTCOcata Therapeutics ...PERRY GREGORY DDirectorGrantA0.00125,0000391,667266.7 K to 391.7 K (+46.87 %)
Jul 09 2012ACTCOcata Therapeutics ...Rabin Gary HCEO & CFOGrantA0.001,000,000015,262,40114.3 M to 15.3 M (+7.01 %)
Jun 19 2012ACTCOcata Therapeutics ...Rabin Gary HCEO & CFOSellS0.07350,00025,09514,262,40114.6 M to 14.3 M (-2.40 %)
Jun 19 2012ACTCOcata Therapeutics ...Rabin Gary HCEO & CFOSellS0.07300,00021,24014,612,40114.9 M to 14.6 M (-2.01 %)
Jun 19 2012ACTCOcata Therapeutics ...Rabin Gary HCEO & CFOSellS0.08175,02913,12714,912,40115.1 M to 14.9 M (-1.16 %)
Apr 18 2012ACTCOcata Therapeutics ...Heffernan Michael ThomasDirectorGrantA0.00100,0000100,0000 to 100 K
Apr 04 2012ACTCOcata Therapeutics ...LOSHITZER ZOHARDirectorGrantA0.00125,0000308,333183.3 K to 308.3 K (+68.18 %)
Apr 04 2012ACTCOcata Therapeutics ...PERRY GREGORY DDirectorGrantA0.00125,0000266,667141.7 K to 266.7 K (+88.24 %)
Apr 03 2012ACTCOcata Therapeutics ...LANGER ROBERTDirectorGrantA0.00125,00003,350,0003.2 M to 3.4 M (+3.88 %)
Feb 27 2012ACTCOcata Therapeutics ...PERRY GREGORY DDirectorOption ExerciseA0.1041,6674,31741,667
Feb 27 2012ACTCOcata Therapeutics ...PERRY GREGORY DDirectorGrantA0.00141,6670141,6670 to 141.7 K
Feb 24 2012ACTCOcata Therapeutics ...LANGER ROBERTDirectorOption ExerciseA0.142,000,000286,0002,000,000
Feb 24 2012ACTCOcata Therapeutics ...LANGER ROBERTDirectorOption ExerciseA0.14125,00017,875125,000
Feb 24 2012ACTCOcata Therapeutics ...LANGER ROBERTDirectorGrantA0.003,000,00003,225,000225 K to 3.2 M (+1,333.33 %)
Feb 24 2012ACTCOcata Therapeutics ...LANGER ROBERTDirectorGrantA0.00225,0000225,0000 to 225 K
Feb 24 2012ACTCOcata Therapeutics ...LOSHITZER ZOHARDirectorOption ExerciseA0.1283,3339,91783,333
Feb 24 2012ACTCOcata Therapeutics ...LOSHITZER ZOHARDirectorGrantA0.00183,3330183,3330 to 183.3 K
Jan 25 2012ACTCOcata Therapeutics ...Lanza RobertChief Scientific Of ...SellS0.196,658,3001,277,72825,957,57532.6 M to 26 M (-20.41 %)
Jan 25 2012ACTCOcata Therapeutics ...Lanza RobertChief Scientific Of ...SellS0.181,000,000175,40032,615,87533.6 M to 32.6 M (-2.97 %)
Sep 30 2011ACTCOcata Therapeutics ...Lanza RobertChief Scientific Of ...SellS0.15608,22593,05833,615,87534.2 M to 33.6 M (-1.78 %)
Sep 30 2011ACTCOcata Therapeutics ...Lanza RobertChief Scientific Of ...SellS0.15108,08016,32034,224,10034.3 M to 34.2 M (-0.31 %)
Sep 30 2011ACTCOcata Therapeutics ...Lanza RobertChief Scientific Of ...SellS0.1510,0001,52034,332,18034.3 M to 34.3 M (-0.03 %)
Aug 25 2011ACTCOcata Therapeutics ...Rabin Gary HCEO & CFOOption ExerciseA0.455,000,0002,250,0005,000,000
Aug 25 2011ACTCOcata Therapeutics ...Rabin Gary HCEO & CFOOption ExerciseA0.305,000,0001,500,0005,000,000
Aug 25 2011ACTCOcata Therapeutics ...Rabin Gary HCEO & CFOOption ExerciseA0.1910,000,0001,850,00010,000,000
Aug 25 2011ACTCOcata Therapeutics ...Rabin Gary HCEO & CFOGrantA0.0010,000,000015,087,4305.1 M to 15.1 M (+196.56 %)
Aug 18 2011ACTCOcata Therapeutics ...Lanza RobertChief Scientific Of ...Option ExerciseA0.1615,000,0002,356,50015,000,000
Aug 18 2011ACTCOcata Therapeutics ...Lanza RobertChief Scientific Of ...GrantA0.0015,000,000034,342,18019.3 M to 34.3 M (+77.55 %)
Jun 30 2011ACTCOcata Therapeutics ...Lanza RobertChief Scientific Of ...Option ExerciseM0.05750,00037,5000
Jun 30 2011ACTCOcata Therapeutics ...Lanza RobertChief Scientific Of ...BuyM0.05750,00037,50019,342,18018.6 M to 19.3 M (+4.03 %)
Jun 03 2011ACTCOcata Therapeutics ...Rabin Gary HCEO & CFOSellS0.20750,000150,5255,087,4305.8 M to 5.1 M (-12.85 %)
May 25 2011ACTCOcata Therapeutics ...Rabin Gary HCEO & CFOSellS0.164,0006285,837,4305.8 M to 5.8 M (-0.07 %)
May 25 2011ACTCOcata Therapeutics ...Rabin Gary HCEO & CFOSellS0.16781,755128,2085,841,4306.6 M to 5.8 M (-11.80 %)
May 25 2011ACTCOcata Therapeutics ...Rabin Gary HCEO & CFOSellS0.16414,24564,2086,623,1857 M to 6.6 M (-5.89 %)
Mar 08 2011ACTCOcata Therapeutics ...Ruoslahti ErkkiDirectorSellS0.17100,00016,6002,744,1192.8 M to 2.7 M (-3.52 %)
Mar 08 2011ACTCOcata Therapeutics ...Ruoslahti ErkkiDirectorSellS0.17150,00025,0502,844,1193 M to 2.8 M (-5.01 %)
Mar 08 2011ACTCOcata Therapeutics ...Ruoslahti ErkkiDirectorSellS0.17250,00041,6502,994,1193.2 M to 3 M (-7.71 %)
Mar 07 2011ACTCOcata Therapeutics ...Ruoslahti ErkkiDirectorSellS0.17250,00042,5003,244,1193.5 M to 3.2 M (-7.15 %)
Mar 03 2011ACTCOcata Therapeutics ...Ruoslahti ErkkiDirectorSellS0.1810,6301,8663,494,1193.5 M to 3.5 M (-0.30 %)
Mar 01 2011ACTCOcata Therapeutics ...Ruoslahti ErkkiDirectorSellS0.18250,00043,7503,504,7493.8 M to 3.5 M (-6.66 %)
Mar 01 2011ACTCOcata Therapeutics ...Ruoslahti ErkkiDirectorSellS0.1872,05012,6093,754,7493.8 M to 3.8 M (-1.88 %)

Page:   < prev 1 2 3 4 next >